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Objectives: Optical coherence tomography (OCT) is a high resolution imaging technique used to assess
superﬁcial atherosclerotic plaque morphology. Utility of OCT may be enhanced by contrast agents tar-
geting molecular mediators of inﬂammation.
Methods and results:Microparticles of iron oxide (MPIO; 1 and 4.5mdiameter) in suspensionwere visu-
alizedandaccuratelyquantiﬁedusinga clinical optical coherence tomography system.Bound toPECAM-1
on a plane of cultured endothelial cells under static conditions, 1m MPIO were also readily detected
by OCT. To design a molecular contrast probe that would bind activated endothelium under conditions
of shear stress, we quantiﬁed the expression (basal vs. TNF-activated; moleculesm−2) of VCAM-1 (not
detected vs. 16±1); PECAM-1 (132±6 vs. 198±10) and E-selectin (not detected vs. 46±0.6) using quan-
titative ﬂow cytometry. We then compared the retention of antibody-conjugatedMPIO targeting each of
these molecules plus a combined VCAM-1 and E-selectin (E +V) probe across a range of physiologically
relevant shear stresses. E +V MPIO were consistently retained with highest efﬁciency (P<0.001) and at a
density that provided conspicuous contrast effects on OCT pullback.
Conclusion:Microparticles of iron oxidewere detectable using a clinical OCT system. Assessment of bind-
ing under ﬂow conditions recommended an approach that targeted both E-selectin and VCAM-1. Bound
to HUVEC under conditions of ﬂow, targeted 1m E+V MPIO were readily identiﬁed on OCT pullback.
Molecular imaging with OCT may be feasible in vivo using antibody targeted MPIO.. Introduction
Optical coherence tomography (OCT) is a high-resolution opti-
al imaging technique with a range of applications in biology
nd medicine. Using a wire-mounted endovascular near-infrared
robe, the walls of coronary arteries can be imagedwith high reso-
ution (∼10m), though with relatively limited depth penetrance.
onsequently, OCT is used to evaluate superﬁcial atherosclerotic
laque morphology [1], including macrophage accumulation [2].
he utility of OCT might be further enhanced by the availability of
olecular imaging contrast agents directed towards targets that
re differentially expressed in pathological states by the vascular
∗ Corresponding author at: Department of CardiovascularMedicine, Level 6,West
ing, John Radcliffe Hospital, Oxford. OX3 9DU, United Kingdom.
el.: +44 1865 234663; fax: +44 1865 234667.
E-mail address: robin.choudhury@cardiov.ox.ac.uk (R.P. Choudhury).
021-9150 © 2011 Elsevier Ireland Ltd.
oi:10.1016/j.atherosclerosis.2011.07.127
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endothelium. Successful molecular imaging approaches have used
reporter particles that include ligand-conjugatedmicrobubbles [3],
micelles [4], liposomes [5] and iron oxide-containing micro- [6] or
nanoparticles [7]. Effective contrast agents for OCT enhance light
scattering, for instance through the use of gold- [8,9] or titanium
dioxide nanoparticles [10].Microparticles of iron oxide (MPIO) also
exert a light scattering effect [11], though they have not been tested
as amonolayer thatwouldbe required for vascularmolecular imag-
ing.
Molecules upregulated in vascular inﬂammation (such as
VCAM-1 [12] and E-selectin [13]) mediate leukocyte adhesion to
activated endothelium and provide an attractive target for imag-
ing and drug delivery. Their prominent position on the luminal
surface of endothelial cells allows ready access to circulating
Open access under CC BY-NC-ND license.ligand−particle complexes. Suchmarkers have been targetedmost
commonly with antibodies, although peptide−protein recognition
and carbohydrate−protein binding provide alternative strategies
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14,15]. However, a major challenge is the delivery of a targeted
articulate contrast agent to the endothelial surface in sufﬁcient
uantities under conditions of high shear stress to permit its iden-
iﬁcation. Critical to the rational design of such contrast agents is
nowledge of (1) the abundance of these targets, (2) the extent
o which their surface expression varies between basal and acti-
ated states, and (3) the ability of contrast particles to bind under
onditions of ﬂow.
Here, we investigate the potency of MPIO targeted to human
ECAM-1, VCAM-1or E-selectin or a combination of VCAM-1 andE-
electin tobind to stimulatedhumanendothelial cells undera range
f shear stress conditions. Using these ﬁndings, we then applied
catheter-mounted clinical OCT system to visualize and quantify
PIO binding to activated endothelial cells in vitro under physi-
logically relevant conditions of shear stress to demonstrate the
ossibility of OCT for molecular imaging of vascular inﬂammation.
. Materials and methods
.1. Cell culture
Primaryhumanumbilical veinendothelial cells (HUVEC, Invitro-
en, Paisley, UK)were cultured inMedium 200 supplementedwith
ow-serumgrowthsupplement (LSGS) (Invitrogen). Cellswereused
etween passages 2 and 5, and when required, stimulated with
ecombinanthuman tumournecrosis factor- (TNF-) (Invitrogen)
t a concentration of 10ngmL−1.
.2. Antibody–MPIO conjugation
Mouse anti-human monoclonal antibodies against VCAM-1
Clone 4B2), E-selectin (5D11) and PECAM-1 (9G11) (R&D Sys-
ems, Abingdon, UK) and an isotype control rat monoclonal IgG2
G2a-1-1) (Southern Biotechnology, Birmingham, USA) antibody
50g for each) were covalently conjugated to ∼1.25×109, 1m
osyl-activated Dynalbeads (MPIO) (Invitrogen). For dual-labelled
-selectin +VCAM-1 (E+V) MPIO, 25g of each antibody was
dded to a labelling reaction to give a total of 50g (as previously
escribed [16]).
.3. Immunocytochemistry and MPIO staining
HUVEC grown on poly-d-lysine coated glass were stimulated
ith TNF- for 8h, washed with PBS and ﬁxed in methanol-
ree formaldehyde 4% for 10min. For immunostaining, cells were
lockedwith 3% BSA. Antibodies to human VCAM-1, E-selectin and
ECAM-1 were incubated with cells at 4 ◦C overnight (ﬁnal con-
entration 20gmL−1) and, after washing, incubated with goat
nti-mouse Alexa Fluor 488 (Invitrogen) (5gmL−1) for 30min
t 37 ◦C. After a ﬁnal wash in PBS, coverslips were mounted on a
tandard microscope slide in SlowFade Gold antifade reagent with
′,6-diamidino-2-phenylindole (Invitrogen). Antibody-attachment
oMPIOwas conﬁrmed by incubating 50ng of antibody–MPIOwith
oat anti-mouse Alexa Fluor 488 (1gmL−1) for 30min at 37 ◦C.
n Olympus IX-71 inverted microscope ﬁtted with a 100×, 1.3
A oil immersion objective (Olympus UK, Southend-on-Sea, UK),
nd a QICAM cooled monochrome CCD camera (QImaging, Surrey,
anada) driven using ImagePro-Plus (Media Cybernetics, Bethesda,
SA) were used.
.4. RNA extraction and RT-PCRQuantitative real-time RT-PCR was used to measure expres-
ion of VCAM-1 (CD106), E-selectin (CD62E) and PECAM-1 (CD31)
n HUVEC under basal conditions and after TNF--stimulation,
sing GAPDH as a normalization gene. Following stimulation withsis 219 (2011) 579–587
TNF- for 4h, RNA was extracted using an RNeasy Mini Kit (Qia-
gen, Crawley, UK) and cDNA was synthesised using a QuantiTect
reverse transcription kit (Qiagen). TaqManTM primers for VCAM-
1, E-selectin, PECAM-1 and GAPDH were used to amplify cDNA
on a StepOne PCR system (Applied Biosystems, Warrington, UK).
Relative quantities of mRNA expressed in arbitrary units were cal-
culated using the 2Ct-method [17].
2.5. Quantitative ﬂow cytometry to establish relative ligand
abundance
Qiﬁkit calibration beads (Dako, Ely, UK)were used as a reference
to determine ligand density from ﬂuorescence intensity. HUVEC
were stimulatedwith TNF- for 8h,washedwith PBS and detached
using non-enzymatic cell dissociation solution (Sigma, Poole, UK).
The cells were centrifuged (1200 rpm; 5min) and resuspended
in 100L PBS. Primary antibodies to VCAM-1, E-selectin and
PECAM-1 and an irrelevant mouse monoclonal anti-human CD68
(R&D Systems) were added at a ﬁnal concentration of 10gmL−1.
Anti-mouse-FITC conjugate (Qiﬁkit, Dako) was added at a dilu-
tion of 1:50. Flow cytometry experiments were performed on a
BD LSRII ﬂow cytometer and the data analysed using Cytobank
(www.cytobank.org).
2.6. Quantitative ﬂow cytometry to establish antibody loading on
MPIO
Antibody–MPIO conjugates (∼2.5×106 MPIOmL−1) were
labelled in suspension with secondary antibody. Alexa Fluor 488
for IgG2, was added at a 200× excess relative to the primary anti-
body. The standard curve generated above was used to calculate
antibody loading density on MPIO.
2.7. Antibody–MPIO binding experiments under static and shear
stress conditions
HUVEC were stimulated with TNF- for 8h, ﬁxed with
4% formaldehyde, washed with PBS and stored at 4 ◦C. For
static binding experiments, antibody–MPIO (10gmL−1 antibody;
∼2.5×108 MPIOmL−1) was added to cells and placed on a bench-
top rocker prior to thoroughwashingwithPBS. Bindingunder shear
stresswasperformedbymountingculturedishesonaParallel-Plate
ﬂow chamber (GlycoTech, Gaithersburg, USA) ﬁtted with gasket
B (0.25 cm×0.025 cm) and connected to a syringe infusion pump
(Pump 22; Harvard Apparatus, Cambridge, USA).
Flow rates to generate the required shear stress conditions
were calculated using the following formula  =6Q/bh2, whereby
 = shear stress (dyne cm−2), Q=ﬂow rate (mL s−1), =viscosity of
liquid (in poise (P); dH2O=0.0076P), b= channel width (cm) and
h= channel height (cm). To simulate a range of physiological shear
stress conditions that are found in the circulatory system, ﬂow
chamber experimentswere conducted at 1, 5, 10 and15dyne cm−2.
MPIO binding after 5min of shear stress was assessed in 20 ran-
dom ﬁelds of view in 4 separate experiments using a 40×, 0.6 NA
objective ﬁtted to the Olympus IX-71 microscope described above.
Clumps of MPIO were counted as a single binding event.
2.8. Assessment of MPIO binding in ex vivo coronary arterioles
Ex vivo, cannulated and pressurized coronary arterioles were
studied with bright ﬁeld and ﬂuorescence videomicroscopy, as
described previously [18,19]. Brieﬂy, with the use of microsurgi-
cal instruments and an operating microscope, the second branch
of septal coronary arteriole (internal diameter 125–150m and
∼1.5mm in length) was isolated from the heart of male Wistar
rats (N=4) and transferred to organ chambers containing two glass
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icropipettes ﬁlled with MOPS (pH 7.4). The vessels were can-
ulated at both ends, and the micropipettes were connected with
ilicone tubing to hydrostatic pressure reservoirs to set the intra-
uminal pressure to 70mmHg. The temperature was set at 37 ◦C
y a circulating bath temperature controller (Grant Instruments,
ambridge, UK).
VCAM-1 MPIO were prepared as described above and adminis-
ered intraluminally to the coronary arteriole at constant ﬂow rate
f 25Lmin−1. Intraluminal ﬂow was generated by changing the
nﬂow and outﬂow pressures in opposite direction, while ﬂow rate
asmeasuredwith a ball-typeﬂowmeter (Omega, Stamford, USA).
he arteriolar diameter was continuously recorded and wall shear
tress was calculated, as described earlier [20].
MPIOs were visualized with whole-ﬁeld ﬂuorescence measure-
ents by using a ultra fast ﬁlter switching-based imaging system
Oligochrome, TILL Photonics, Uckﬁeld, UK) on a Nikon Eclipse FN1
icroscope (Nikon, Kingston-upon-Thames, UK) equipped with
20× water dipping objective (NA 0.5) and illuminated with
75/35nm light. Fluorescent images were acquired with an Andor
uca (S) cooled EM CCD camera (Andor, Belfast, Northern Ireland)
t 10Hz. Images were analysed off-line using Arivis Browser (TILL
hotonics). Small regionsof interest (1000m2)were selectedover
he surface of endothelial layer andMPIOswere countedmanually.
he number of bound MPIO were averaged in these regions and
resented as binding events per 1000m2.
Following basal ﬂow experiments, ex vivo coronary arterioles
ere stimulatedwithTNF- (7.25nmol L−1, for 4h) andMPIObind-
ng events were recorded after stimulation.
.9. Western immunoblotting
Single coronary arterioles (1 vessel from each animal) were
issected from the heart of Wistar rats. Cleared of connective
issue and placed into MOPS (37 ◦C, pH 7.4). Coronary arteri-
les were incubated with or without TNF- (7.25nmol L−1) for
h and then vessels were snap-frozen in liquid nitrogen. Arte-
ioles were homogenized in 20L ice-cold RIPA buffer (Sigma)
nd additional 20L of Laemmli buffer were added (Sigma) and
DS electrophoresis and consequent immunoblot analysis was car-
ied out as described earlier [18]. Anti-VCAM-1 and anti--actin
rimary and respective horseradish peroxidise-labelled secondary
ntibodies were used for protein detection. Signals were revealed
ith chemiluminescence and visualized autoradiographically.
.10. MPIO phantom and ﬂow chamber dish preparation for OCT
maging
Suspensions of MPIO in 0.4% agarose were prepared in glass
ubesatdensitiesof3, 2and0.12×106 MPIOmL−1 for4.5mMPIO,
nd 5 and 2.5×108 MPIOmL−1 for 1m MPIO.
For monolayer experiments, PECAM-1–MPIO (1m) were
dded to a dish of ﬁxed HUVEC and incubated under static condi-
ions described above. A 20-gauge venous cannula (BDBiosciences)
rovided a track for the OCT catheter immediately above the cell
onolayer. E +V–MPIOwere run through theﬂowchamberat shear
tresses of 1 and 5dyne cm−2.
OCT was performed using a C7 Dragonﬂy Catheter connected
o a C7-XR OCT Intravascular Imaging System (LightLab, St Paul,
SA). A 15mm pullback (0.5mms−1) was used to image bound
ntibody–MPIO. The signal or contrast generated by the MPIO was
easuredby thresholding the images to apixel intensity 2 standard
eviations above the background, and then measuring the area of
ignal above threshold using ImageJ (NIH, Bethesda, USA).sis 219 (2011) 579–587 581
2.11. Statistical analysis
Two-tailed, unpaired Student’s t-tests were used for all statisti-
cal comparisons.
3. Results
3.1. Optical coherence tomography characteristics of MPIO
MPIO dispersed in suspension produced a light scattering effect
represented as discreet regions of bright signal in the OCT image.
Larger MPIO resulted in brighter and more distinct signal, with the
4.5m particles conspicuous as punctuate spots. The 1m MPIO
were clearly detectable abovebackground, though in amorediffuse
pattern (Fig. 1).
OCT was next applied to image MPIO in a single plane on a
monolayer of endothelial cells, rather than suspended in a vol-
ume. PECAM-1-targeted 1m MPIO were allowed to bind under
static conditions to a monolayer of HUVEC, which constitutively
express PECAM-1, represented in Fig. 2A. Bound MPIO appeared
as an intensely bright band along the cell surface (Fig. 2B), with
homogeneous low signal in the ‘no-MPIO’ control (Fig. 2C). The sig-
nal intensity proﬁle of a line drawn across the monolayer (Fig. 2D)
shows clear demarcation of MPIO from adjacent cells/agarose. This
marked contrast effect was consistent along a 10mm automated
pullback anda signiﬁcantdifference in themeanpixel intensitywas
observed between PECAM-1–MPIO and no MPIO controls (Fig. 2E).
3.2. Expression of inﬂammatory markers in cell model
Immunocytochemistry demonstrated endothelial localisation
of VCAM-1 and E-selectin in TNF- stimulated cells and PECAM-
1 in both basal and activated states (Supplementary Fig. 1A–C).
Real-time quantitative RT-PCR showed marked TNF- induced
expression of VCAM-1 and E-selectin in HUVEC cultures com-
pared to the basal state. PECAM-1 was constitutively expressed,
with comparable mRNA levels in stimulated and basal HUVEC
(Supplementary Fig. 1D–F).
3.3. Quantitative ﬂow cytometry to establish target abundance
on endothelial cells
In the basal state, VCAM-1 and E-selectin were undetectable,
while PECAM-1 was present at 132±6moleculesm−2. In TNF-
stimulated cells, VCAM-1 and E-selectin were expressed, at ligand
densities of 16±1 and 46±0.6moleculesm−2, respectively, and
PECAM-1 density rose to 198±10moleculesm−2. The anti-CD68
control was negative under each condition (Supplementary Table
1 and Fig. 2). The density of E-selectin was signiﬁcantly greater
than that of VCAM-1 (P=0.001), while the density of PECAM-1 was
signiﬁcantly greater than both inducible markers (P≤0.002).
3.4. Quantitative ﬂow cytometry to establish antibody density on
MPIO
Loading densities of VCAM-1, E-selectin, PECAM-1 and IgG2
antibodies conjugated to 1m MPIO were also assessed. Fluores-
cence intensity histograms generated fromﬂowcytometry analysis
of antibody-labelled MPIO (Supplementary Fig. 3) suggested that
90–95% of MPIO were labelled with antibody. The density was
calculated to be 27,100±1920 molecules per MPIO for all anti-
bodies; equivalent to 8500moleculesm−2. Therefore, the ligand
density on the MPIO far exceeds the target density on the cell; a
fundamental pre-requisite if MPIO binding is to be used for target
quantiﬁcation.
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Fig. 1. Contrast optical coherence tomography. The commercially available LightLab C7-XR OCT Intravascular Imaging System used in this study (A). Optical coherence
tomography reveals minimal background scatter (B) of the 0.4% agarose used in the preparation of MPIO phantoms. 4.5m MPIO at variable concentration in an arterial
phantom (C) were quantiﬁable using automated analysis of OCT data (D), and visible as punctuate spots in the image (E). 1m MPIO in a phantom (F) were also quantiﬁable
(G), and visible as punctuate spots in the image (H).
Fig. 2. Optical coherence tomography of MPIO on a cell monolayer. (A) A cartoon representation of antibody-labelled MPIO [red] binding to endothelial cell surface markers
[yellow]. The PECAM-1–MPIO bound to the cell monolayer are visible as a bright horizontal band in the OCT image (B). ‘No-MPIO’ control experiment conﬁrms background
signal is minimal (C). The intensity proﬁle of a line drawn perpendicular to the monolayer with PECAM-1–MPIO bound reveals a clear demarcation between MPIO and
surrounding agarose and cells (D). Areas of measurable signal along the pullback are signiﬁcantly greater for PECAM-1–MPIO compared with the no MPIO control (E) (Error
bars represent ±1 SEM). (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of the article.)
A. Jefferson et al. / Atherosclero
Fig. 3. Binding of E-selectin-, VCAM-1-, E +V-, PECAM-1- and IgG2–MPIO to TNF-
stimulated and basal HUVEC. In stimulated cells under static and low shear stress
conditions, antibody–MPIO to E-selectin, VCAM-1 and E+V bind in greater numbers
than PECAM-1–MPIO. However, as shear stress increases, PECAM-1–MPIO bind in
signiﬁcantly greater numbers than the other antibody–MPIO (A). In basal cells, only
antibody–MPIO targeted to the constitutively expressed PECAM-1 are able to bind
above background (B).
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tata points are expressed as mean MPIO bound per ﬁeld of view (MPIO/fov), with
rror bars representing ±1 SEM.
.5. Antibody-conjugated-MPIO binding under static conditions
In basal state, there was sparse retention of MPIO targeting E-
electin, VCAM-1, E-selectin +VCAM-1 in combination (“E +V”) and
he IgG2 negative control. Conversely PECAM-1–MPIObound abun-
antly even in basal state. TNF--stimulation greatly increased
inding for E-selectin, VCAM-1 and ‘E +V’ but was unchanged
or both PECAM-1 and the IgG2 negative control, consistent with
pregulation of E-selectin and VCAM-1 under cytokine stimulation
Tale 1 and Fig. 3). Binding of E +V–MPIO was signiﬁcantly higher
han all other antibody–MPIO tested (P<0.001). E-selectin–MPIO
ound signiﬁcantly more than both VCAM-1- and PECAM-1–MPIO
P=0.004). There was no signiﬁcant difference between binding of
CAM-1- and PECAM-1–MPIO under static conditions (P=0.26).
.6. Antibody–MPIO binding under conditions of shear stress
In general, antibody–MPIObinding fell as shear stress increased;
he binding of antibody–MPIO seen at 1dyne cm−2 greatly reduced
pon increasing shear stress to 5dyne cm−2 and higher, par-
icularly that of VCAM-1–MPIO. In the like-for-like comparison,
-selectin–MPIO generally bound in greater numbers than VCAM-
–MPIO. Of particular note, the dual-labelled E+V–MPIO bound in
igniﬁcantly higher numbers than all other antibody–MPIO target-
ng inducible mediators of inﬂammation (P<0.001 for all), with
he exception of binding slightly less than E-selectin–MPIO atsis 219 (2011) 579–587 583
10dyne cm−2, suggesting a synergistic effect of antibodies to differ-
ent targetsona singleMPIO. Inkeepingwith theobservationsunder
static conditions (above), minimal binding of E-selectin-, VCAM-1-,
E +V- and IgG2–MPIO was observed in basal cells. PECAM-1–MPIO,
while not indicative of activated endothelium, bound in higher
numbers at higher shear stress than the other antibody–MPIO.
3.7. MPIO binding in ex vivo coronary arterioles
VCAM-1–MPIO were delivered intraluminally into isolated,
pressurized arterioles at constant ﬂow rate of 25Lmin−1. The
25Lmin−1 ﬂow elicited 5–10dyne cm−2 wall shear stress in
125–150m diameter arterioles, close to shear stress levels to
which these vessels are exposed in vivo. Under these conditions
we detected real-time ﬁrm binding of VCAM-1–MPIO (Fig. 4A and
B and Movie), events that were enhanced when coronary arteri-
oles were exposed to TNF-. Correspondingly, TNF- stimulation
resulted in an increased protein expression of VCAM-1 in coronary
arterioles (Fig. 4C).
3.8. Optical coherence tomography of MPIO bound under shear
stress
In order to assess the capability of OCT to image targeted
MPIO on a monolayer at physiologically relevant retention lev-
els, E +V–MPIO were exposed to TNF--stimulated HUVEC with
non-stimulated cells as a negative control. E +V–MPIO bound to
stimulated cells at 1dyne cm−2 could be identiﬁed using OCT, by
measuring pixel area above a threshold set to 2 standard devi-
ations above background. Despite the variability in MPIO signal
along the pullback, a substantial difference was observed between
E+V–MPIO on stimulated cells vs. on basal (107 pixels above
threshold±33 vs. 18 pixels±22; P<0.0001). At 5dyne cm−2 bind-
ing of E +V–MPIO was diminished but was 2.5-fold greater than
the negative control (42 pixels±45 vs. 16 pixels±13; P=0.0012)
(Fig. 5).
4. Discussion
Optical coherence tomography provides high-resolution
anatomical images of coronary arteries and associated pathology.
Here, we designed and evaluated in vitro a new molecular OCT
imaging agent targetingmolecules that are differentially expressed
by activated endothelial cells. Light-scattering particles of iron
oxide provided conspicuous contrast when bound to the activated
endothelium under conditions of shear stress that were designed
to mimic in vivo binding.
To date, a range of particles have been used to enhance signal
for OCT. Gold nanoparticles demonstrate a light scattering effect
[9] and immuno-targeting has allowed them to be used in live
cell studies [21]. Particles of iron oxide have excellent light scat-
tering properties [11]. Furthermore, the surfaces of such particles
can be functionalised to allow loading with speciﬁc ligands target-
ing vascular endothelium [16]. As expected, the light scattering and
therefore contrast effects of larger particles were greater, but even
1mMPIOwere readily identiﬁable with OCT. However, given the
known tendency for ≥4.5m particles to be retained by the lungs
after intra-venous injection [16], we elected to evaluate the smaller
(1m) MPIO in subsequent experiments.
A number of imaging and therapeutic approaches have suc-
cessfully targeted adhesion molecules that are involved in the
recruitment of circulating leukocytes to sites of local inﬂamma-
tion [3,6,22]. While the roles of adhesion molecules in cellular
recruitment have been partially deﬁned [15], their relative abili-
ties to mediate binding of antibody-conjugated inert particles is
584 A. Jefferson et al. / Atherosclerosis 219 (2011) 579–587
Table 1
Antibody–MPIO binding to endothelial markers under static and shear stress conditions.
Antibody–MPIO Binding conditions TNF- stimulated HUVEC Basal HUVEC
Binding events per fov SEM Binding events per fov SEM
E-Selectin Static 60 6.5 3.1 0.6
VCAM-1 38 2.8 0.33 0.4
E+V 73 2.9 0.6 0.2
PECAM-1 33 4 32 3.4
IgG2 3 0.7 1.65 0.5
E-selectin 1dyne cm−2 18 1.2 0.2 0.07
VCAM-1 26 2.5 0.625 0.2
E+V 33 1.3 0.45 0.09
PECAM-1 27 0.7 27 0.8
IgG2 0.13 0.04 0.2 0.06
E-selectin 5dyne cm−2 6.3 0.6 0.1 0.08
VCAM-1 1.1 0.2 0.01 0.02
E+V 10.9 0.8 0.2 0.1
PECAM-1 29 1.3 30 1.2
IgG2 0.04 0.05 0.03 0.05
E-selectin 10dyne cm−2 5.7 0.6 0.075 0.07
VCAM-1 0.1 0.05 0.0125 0.02
E+V 4 0.3 0.2 0.1
PECAM-1 18 1.2 18 1
IgG2 0.04 0.05 0.03 0.03
E-selectin 15dyne cm−2 1.45 0.4 0.03 0.03
VCAM-1 0.09 0.08 0.04 0.04
u
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VE+V 0.7
PECAM-1 6.6
IgG2 0.075
nexplored. To fully capitalise on these properties, requires appre-
iation of (a) the density of the target and (b) the extent to which
ts expression changes between basal and activated states and (c)
he relative afﬁnities of ligand and ligand combinations for these
argets, including under conditions of shear stress.
ig. 4. Representative microphotographs show isolated, pressurized coronary arterioles
rteriole, whereas ﬂuorescent (FITC excited) images show VCAM-1–MPIO (arrowheads) a
timulation with TNF- (7.25nmol L−1 for 4-h, right panel). VCAM-1–MPIO were deliver
ean binding events in isolated coronary arterioles were signiﬁcantly higher in TNF- st
CAM-1 and -actin in coronary arterioles before (basal) and after stimulation with TNF-0.3 0.04 0.04
1.0 10.2 2.3
0.08 0.05 0.06
While PECAM-1 was the most abundant target molecule, this
study conﬁrmed its constitutive expression and lack of regu-
lation in response to a pro-inﬂammatory stimulus. In contrast,
both E-selectin and VCAM-1 were markedly up-regulated from
undetectable levels, and therefore more suitable as targets for
(internal diameter: 100m) of the rat. Left panel shows bright ﬁeld image of the
dhered to the endothelial cells before (basal, shown in the middle panel) and after
ed intraluminally into the pressurized arteriole at the ﬂow rate of 25Lmin−1 (A).
imulated vessel than in basal tissue (B). Western immunoblots show expression of
 (7.25nmol L−1 for 4-h).
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Fig. 5. OCT imaging of MPIO binding to E-selectin and VCAM-1 under conditions of shear stress. Binding of E +V–MPIO at 1dyne cm−2 was detectable using OCT, and the
particles bound to the cell monolayer were clearly visible (A). No signal was seen in the basal control at 1dyne cm−2 (B). The intensity proﬁle of a line drawn perpendicular
to the monolayer with PECAM-1–MPIO bound reveals a clear demarcation between MPIO and surrounding agarose and cells (C). Area of signal generated by the E+V–MPIO
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binding at 1dyne cm−2 in the OCT images is signiﬁcantly higher in the stimulated c
dyne cm−2 results in a lower signal area, but which is still signiﬁcantly greater tha
istinguishing pathological states. The design of a contrast agent
hould take into consideration the abundance and location of the
arget. Based on our ﬁndings, targets at a low abundance may only
edetectablebyparticles at relatively lowshear stress,whilehigher
bundance targetsmay be detected across a broader range of shear
tress conditions.
The dynamics of leukocyte–endothelial binding are complex
nd dependent on multiple receptor–ligand interactions. Initial
eukocyte rolling is selectin-mediatedwhile ﬁrm adhesion ismedi-
ted by integrin binding to ICAM-1 and VCAM-1, with the latter
ore important in initiation of atherosclerosis. ‘Adhesion dynamic
odelling’ predicts synergistic roles for selectins and integrinswith
ransition between rolling andﬁrmadhesiondependent onbinding
fﬁnities and relative concentrations of receptor–ligand interac-
ions [23,24]. Taking this into consideration, we have previously
dopted a dual antibody-conjugated MPIO approach for targeted
RI and applied this to the detection of adhesion molecules on
he arterial endothelium of apolipoprotein E knockout (apoE−/−)
ice in vivo [16]. The current in vitro data corroborate this: the
-selectin and VCAM-1 antibodies on the dual labelled MPIO com-
ined synergistically to enhance particle binding across a wide
ange of shear stress conditions compared with the constituent
ingle-targeted particles. Our dual-labelled E+V MPIO bound in
ufﬁcient numbers to allow detection with OCT enabling dis-
inction of activated and basal endothelium under shear stress
onditions that are representative of venous to arterial blood
ow.
We corroborated our in vitro ﬁndings with an ex vivo exper-ment using rat coronary arterioles as a model of inﬂammation.
sing ﬂuorescently labelled VCAM-1–MPIO, we demonstrated the
apacity of targeted MPIO to differentiate between inﬂamed and
asal endothelium under conditions of shear stress.an in the basal controls (D&E), while the reduction in binding to stimulated cells at
basal equivalent (E). Error bars represent ±1 SEM.
We developed a cell-based in vitro model because of the abil-
ity to isolate and control variables inﬂuencing antibody–MPIO
binding. We have previously reported binding of MPIO in mouse
atherosclerosis, acute brain inﬂammation and in brain and renal
ischemia–reperfusion injury, and the ability of MPIO to bind under
conditions of ﬂow, in vivo, is established [6,16]. In vivo, however,
multiple variables may contribute to differential binding of MPIO,
including: (1) ligand–target pairing; (2) target density; (3) shear
forces; (4) speciﬁc anatomy. The purpose of the current approach
was to vary (a) shear and (b) ligand–target pairing in a controlled
fashion and to evaluate the contributions of each, thereby aiding
rational contrast agent design. HUVEC were selected as they are a
well-characterised model of inﬂammation [25,26] that have been
previously used in leukocyte adhesion assays [27,28].
4.1. Limitations
This study and others have employed antibodies as targeting
ligands. While antibodies can provide both high afﬁnity and speci-
ﬁcity, they are not the endogenous ligands for either integrins or
selectins and our ﬁndings cannot be extrapolated to the binding
of leukocytes in vivo. Nor can the results, with the speciﬁc anti-
bodies used in this study, be generalised to all antibodies-target
interactions, since variation in epitope and afﬁnitymay affect bind-
ing properties. Furthermore, antibodies are expensive to produce,
and are capable of inducing an immune response in the host, so
“humanisation” of animal antibodies would be required for safe
use of suchMPIO in humans. For these reasons alternative targeting
strategies are under development. Recently, synthetic sialyl Lewisx,
a carbohydrate found on the surface ofmost leukocyte populations,
has been used to target glyconanoparticles to E- and P-selectin in
brain inﬂammation and a VCAM-1 speciﬁc peptide, generated by
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hage display [29,30] has also been successfully used as a targeting
olecule to image inﬂammatory atherosclerosis.
.2. Imaging of MPIO endothelial targeted MPIO using OCT
MPIObound to activated endotheliumunder conditions of shear
tress were clearly identiﬁed. The in vitro system comprising of the
onolayer of cells and agarose providedminimal background scat-
ering with OCT and so despite the MPIO signal variability, a clear
nd statistically signiﬁcant demarcation could be made between
he presence or absence of bound MPIO, reﬂective of the inﬂamed
r basal states. The in vivo environment and presence of different
issues, however, may produce more scattering, although unla-
elled gold-coated protein microspheres been visualized via OCT
n murine liver with minimal scatter from the native vasculature.
Should background scatter prove problematic, developments
r reﬁnements to the OCT protocol may improve the signal or
ontrast effect of imaging particles. For instance, differential phase-
CT has been described, whereby magnetic microparticles were
xcited by the application of an oscillating magnetic ﬂux density
nd the improved contrast effect used to image macrophage inﬁl-
ration in atherosclerotic plaque [31] and this technique would be
irectly applicable when targeted MPIO are used. Larger diame-
ermicroparticles provide enhanced scattering effects over smaller
articles, but theymaybeundesirable in other aspects [16]; smaller
articles decorated with optically active elements are also under
nvestigation. In addition to quantiﬁcation of molecular expression
rom the use of targeted imaging agent, OCT also provides comple-
entary high-resolution morphological information on vessel and
laque structure [1]. OCT could be combinedwith non-invasiveMR
maging to provide a hybrid imaging strategy; inﬂammation and
laque formation could ﬁrst be identiﬁed using MRI, which could
hen be followed up with OCT at the time of coronary intervention
o further characterise the plaque composition and morphology.
. Conclusions
Microparticles of iron oxide (1 and 4.5m) were detectable
sing a commercially available optical coherence tomography sys-
emand imaging probe. Functionalised particles bearing antibodies
o a range of endothelial targets were generated. Quantiﬁcation of
argets (E-selectin, VCAM-1 and PECAM-1) in cultured endothelial
ells in a basal state and after TNF- stimulation identiﬁed poten-
ial targets for molecular imaging. Assessment of binding under
ow conditions recommended a combined approach that targeted
oth E-selectin andVCAM-1, as predicted fromearlier in silicomod-
lling and in vivo binding in mice. Bound under conditions of ﬂow,
argeted MPIO were readily identiﬁed on OCT pullback. Molecular
maging with OCT may be feasible in vivo using antibody targeted
PIO and combined with MR imaging to provide hybrid imaging
pproaches.
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